Announce Date | 04/28/2025 |
EPS Normalized Actual | $0.19 (Miss by $-0.06) |
EPS GAAP Actual | $0.19 (Miss by $-0.06) |
Revenue Actual | $2.103B |
Revenue Surprise | Beat by $2103M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.29 | 5.64 | 2.20891 | 2.3537 | 2 |
Dec 2027 | 2.21 | 5.85 | 2.13174 | 2.27147 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.19 | 0.19 | 2.103B | -2.47% | 2103M |
FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 2.308B | -1.52% | 2308M |
FQ3 2024 (Sep 2024) | 0.33 | 0.33 | 2.191B | 0.27% | 2191M |
FQ2 2024 (Jun 2024) | 0.57 | 0.57 | 2.216B | 5.55% | 2216M |
FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 2.155B | 8.96% | 2155M |
FQ4 2023 (Dec 2023) | 1.52 | 1.52 | 2.343B | 11.52% | 2343M |
FQ3 2023 (Sep 2023) | 0.29 | 0.29 | 2.185B | 13.55% | 2185M |
FQ2 2023 (Jun 2023) | 0.39 | 0.39 | 2.093B | 17.49% | 2093M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 0.5402 | -- | 0.52314 | 0.56243 | 2 |
FQ3 2029 (Sep 2029) | 0.5601 | -- | 0.54021 | 0.61919 | 9 |
FQ2 2029 (Jun 2029) | 0.54 | -- | 0.52083 | 0.59697 | 6 |
FQ1 2029 (Mar 2029) | 0.5048 | -- | 0.48688 | 0.55806 | 4 |
FQ4 2028 (Oct 2028) | 0.5362 | -- | 0.5362 | 0.5362 | 15 |
FQ3 2028 (Jul 2028) | 0.5119 | -- | 0.5119 | 0.5119 | 8 |
FQ2 2028 (Jun 2028) | 0.5119 | -- | 0.49047 | 0.52424 | 8 |
FQ1 2028 (Mar 2028) | 0.4854 | -- | 0.46508 | 0.4971 | 9 |
FQ4 2027 (Oct 2027) | 0.5085 | -- | 0.5085 | 0.5085 | 10 |
FQ3 2027 (Jul 2027) | 0.4861 | -- | 0.4861 | 0.4861 | 7 |
FQ2 2027 (Jun 2027) | 0.4861 | -- | 0.46575 | 0.49782 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 2.68B | -- | 2.62B | 2.76B | 12 |
FQ3 2029 (Sep 2029) | 2.54B | -- | 2.47B | 2.75B | 9 |
FQ2 2029 (Jun 2029) | 2.53B | -- | 2.46B | 2.73B | 8 |
FQ1 2029 (Mar 2029) | 2.51B | -- | 2.44B | 2.71B | 7 |
FQ4 2028 (Oct 2028) | 2.46B | -- | 2.46B | 2.46B | 5 |
FQ3 2028 (Jul 2028) | 2.44B | -- | 2.44B | 2.44B | 5 |
FQ2 2028 (Jun 2028) | 2.49B | -- | 2.41B | 2.54B | 5 |
FQ1 2028 (Mar 2028) | 2.48B | -- | 2.4B | 2.52B | 5 |
FQ4 2027 (Oct 2027) | 2.39B | -- | 2.39B | 2.39B | 6 |
FQ3 2027 (Jul 2027) | 2.37B | -- | 2.37B | 2.37B | 6 |
FQ2 2027 (Jun 2027) | 2.42B | -- | 2.34B | 2.47B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.19 | 0.19 | 100% | |
FQ4 2024 (Dec 2024) | 0.41 | 0.41 | 100% | |
FQ3 2024 (Sep 2024) | 0.33 | 0.33 | 100% | |
FQ2 2024 (Jun 2024) | 0.57 | 0.57 | 100% | |
FQ1 2024 (Mar 2024) | 0.3 | 0.3 | 100% | |
FQ4 2023 (Dec 2023) | 1.52 | 1.52 | 100% | |
FQ3 2023 (Sep 2023) | 0.29 | 0.29 | 100% | |
FQ2 2023 (Jun 2023) | 0.39 | 0.39 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.1B | $2103M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.31B | $2308M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.19B | $2191M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.22B | $2216M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.16B | $2155M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.34B | $2343M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.19B | $2185M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.09B | $2093M | 100% |